The self-antigens that are presented by MR1 that is expressed by tumours or metabolically altered cells have not yet been characterized, but it is already clear that there are likely different groups of antigens, since individual MR1T clones distinguish between different purified antigen fractions and can also differentially recognize distinct tumour cells (9). The gene discussed is MR1; the disease is neoplasm.